Topwin Cangerzi San
Natural health product licensed in Canada
- Other names
- Cangerzi San, Topwin Cangerzi San Granule
- Licence holder
- Topwin Trading Co., Ltd.
- NPN or DIN-HM
- 80101383
- Status
- Active licence
- Licence date
- 4 June 2020
- Revision date
- Not provided
- Form
- Granules
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnolia biondii Source : Fleur Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Xanthium sibiricum Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Mentha canadensis Source : Sommité Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Scutellaria baicalensis Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Angelica dahurica Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Ligusticum sinense cv. chuanxiong Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Fritillaria cirrhosa Source : Bulbe Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Glycine max Source : Graine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Chrysanthemum x morifolium Source : Fleur Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
| Glycyrrhiza uralensis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 mg | Not calculated |
Non-medicinal ingredients
Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Mesures | 2 Tous les jours |
Uses authorised in Canada
Preparation based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80101383
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.